Download PDF
psychoneuro 2008; 34(8): 355-360
DOI: 10.1055/s-0028-1087114
Schwerpunkt

© Georg Thieme Verlag Stuttgart · New York

Kognitive Störungen bei Multipler Sklerose – Erhebliche Auswirkungen auf Alltag und Lebensqualität

Cognitive symptoms in multiple sclerosis – Highly relevant for daily functioningChristoph Heesen1 , Jana Poettgen1 , Rüdiger Groß2
  • 1Institut für Neuroimmunologie und klinische MS–Forschung, Hamburg(Institutsdirektor: Prof. Dr. R. Martin)
  • 2Neurologisches Zentrum, Segeberger Kliniken, Bad Segeberg (Chefarzt: Prof. Dr. J. M. Valdueza)
Further Information

Publication History

Publication Date:
28 August 2008 (online)

    Permissions and Reprints

Kognitive Störungen bei Multipler Sklerose (MS) sind lange Zeit unterschätzt worden. Mittlerweile ist eine Prävalenz von 30–70 % gesichert. Weniger klar ist der Verlauf, wobei die Datenlage bislang zeigt, dass nur bei einem Teil der Betroffenen deutlich progrediente Störungen auftreten. Hauptbetroffen sind Informationsverarbeitungsgeschwindigkeit und Aufmerksamkeit. Morphologisches Korrelat scheint weniger die Läsionslast als die degenerative Komponente der Erkrankung zu sein, die aktuell am solidesten in der Gesamthirnatrophie abgebildet ist. Die Alltagsrelevanz für Berufstätigkeit und Lebensqualität ist erheblich. Sensitive Screeninginstrumente existieren, die Korrelation zu Alltagsfunktionen ist dabei wenig untersucht. Immunmodulatoren scheinen auch die Entwicklung kognitiver Störungen abzubremsen, wobei die Datenlage hier spärlich ist. Der Nutzen von Antidementiva ist nicht gut belegt. Einige Therapiestudien deuten einen Nutzen kognitiver Rehabilitation bei MS an; die vorhandenen Studien werden in dieser Übersicht vorgestellt. Wesentliche Fragen zur Wirksamkeit der Rehabilitation wie beispielsweise der Nutzen von Kompensationstechniken vs. Trainingstechniken und die Bedeutung für den Alltag sind ungeklärt. Informationen zu kognitiven Störungen werden, wenn patientengerecht aufgearbeitet, als hilfreich empfunden und können zur Enttabuisierung des Themas beitragen.

Cognitive symptoms in multiple sclerosis have long been not recognized. The prevalence is now estimated to range between 30–70 %. Few studies exist on the long–time evolution. It seems that only a smaller subgroup of patients develops substantial progressive decline. Major domains of affection are information processing and attention. The closest association to morphological parameters on MRI is with measures of brain atrophy. The relevance of cognitive disturbances for daily living and quality of life is high. Sensitive screening instruments nowadays exist but their correlation to daily activities has not been rigorously studied. Immune modulating agents seem to slow progressive decline but again the evidence is weak. Effects of cholinergic drugs or other drugs acting on cognitive processing have not been studied in larger series. There is some evidence on the effectiveness of neuropsychological rehabilitation but as reviewed in the paper data are not conclusive on the improvement of quality of life and daily functioning. Information on cognitive disturbances is considered helpful from the patient view depending on the framing of presentation.

Key words

Multiple sclerosis - cognition - rehabilitation - treatment

Literatur

  • 1 Rao SM, Leo GJ, Bernardin L, Unverzagt F.. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.  Neurology. 1991;  41 685-691
    CrossrefPubMedGoogle Scholar
  • 2 Amato MP, Ponziani G, Siracusa G, Sorbi S.. Cognitive dysfunction in early–onset multiple sclerosis: a reappraisal after 10 years.  Archives of neurology. 2001;  58 1602-1606
    CrossrefPubMedGoogle Scholar
  • 3 Rao V. A. Psychiatric morbidity in the aged.  The Indian journal of medical research. 1997;  106 361-369
    PubMedGoogle Scholar
  • 4 Glanz BI, Holland CM, Gauthier SA. et al. . Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.  Multiple sclerosis (Houndmills, Basingstoke, England). 2007;  13 1004-1010
    CrossrefPubMedGoogle Scholar
  • 5 Feuillet L, Reuter F, Audoin B. et al. . Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis.  Multiple sclerosis (Houndmills, Basingstoke, England). 2007;  13 124-127
    CrossrefPubMedGoogle Scholar
  • 6 Rao SM.. Neuropsychology of multiple sclerosis.  Current opinion in neurology. 1995;  8 216-220
    PubMedGoogle Scholar
  • 7 Beatty WW.. Assessment of cognitive and psychological functions in patients with multiple sclerosis: considerations for databasing.  Multiple sclerosis (Houndmills, Basingstoke, England). 1999;  5 239-243
    PubMedGoogle Scholar
  • 8 Amato MP, Ponziani G, Amaducci L.. Cognitive impairment in multiple sclerosis: a longitudinal study.  Electroencephalography and clinical neurophysiology. 1999;  50 465-468
    PubMedGoogle Scholar
  • 9 Langdon DW, Thompson AJ.. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome.  Multiple sclerosis (Houndmills, Basingstoke, England). 1999;  5 94-100
    PubMedGoogle Scholar
  • 10 Arnett PA, Rao SM, Grafman J. et al. . Executive functions in multiple sclerosis: an analysis of temporal ordering, semantic encoding, and planning abilities.  Neuropsychology. 1997;  11 535-544
    CrossrefPubMedGoogle Scholar
  • 11 Kujala P, Portin R, Ruutiainen J.. The progress of cognitive decline in multiple sclerosis. A controlled 3–year follow–up.  Brain. 1997;  120 289-297
    CrossrefPubMedGoogle Scholar
  • 12 Amato MP, Ponziani G, Pracucci G. et al. . Cognitive impairment in early–onset multiple sclerosis. Pattern, predictors and impact on everyday life in a 4–year follow–up.  Arch Neurol. 1995;  52 168-172
    CrossrefPubMedGoogle Scholar
  • 13 Achiron A, Polliack M, Rao SM. et al. . Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves.  J Neurol Neurosurg Psychiatry. 2005;  76 744-749
    CrossrefPubMedGoogle Scholar
  • 14 Schwid SR, Goodman AD, Weinstein A, McDermott MP, Johnson KP.. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10–year clinical trial.  J Neurol Sci. 2007;  255 57-63
    CrossrefPubMedGoogle Scholar
  • 15 Benedict RH, Carone DA, Bakshi R.. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.  J Neuroimaging. 2004;  14 36-45
    CrossrefPubMedGoogle Scholar
  • 16 Gold SM, Schulz H, Mönch A, Schulz KH, Heesen C.. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self–report health measures.  Multiple sclerosis (Houndmills, Basingstoke, England). 2003;  9 404-410
    CrossrefPubMedGoogle Scholar
  • 17 Deloire MS, Bonnet MC, Salort E. et al. . How to detect cognitive dysfunction at early stages of multiple sclerosis?.  Multiple sclerosis (Houndmills, Basingstoke, England). 2006;  12 445-452
    CrossrefPubMedGoogle Scholar
  • 18 Sepulcre J, Vanotti S, Hernandez R. et al. . Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery–Neuropsychology test.  Multiple sclerosis (Houndmills, Basingstoke, England). 2006;  12 187-195
    CrossrefPubMedGoogle Scholar
  • 19 Parmenter BA, Weinstock–Guttman B, Garg N, Munschauer F, Benedict RH.. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.  Multiple sclerosis (Houndmills, Basingstoke, England). 2007;  13 52-57
    CrossrefPubMedGoogle Scholar
  • 20 Beatty WW, Goodkin DE.. Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini–Mental State Examination.  Arch Neurol. 1990;  47 297-301
    CrossrefPubMedGoogle Scholar
  • 21 Benedict RH, Fischer JS, Archibald CJ. et al. . Minimal neuropsychological assessment of MS patients: a consensus approach.  Clinical Neuropsychology. 2002;  16 381-397
    CrossrefPubMedGoogle Scholar
  • 22 Calabrese P, Kalbe E, Kessler J.. Das Multiple Sklerose Inventarium Cognition (MUSIC).  psychoneuro. 2004;  30 384-388
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Shawaryn MA, Schultheis MT, Garay E, Deluca J.. Assessing functional status: exploring the relationship between the multiple sclerosis functional composite and driving.  Arch Phys Med Rehabil. 2002;  83 1123-1129
    CrossrefPubMedGoogle Scholar
  • 24 Goverover Y, Genova HM, Hillary FG, DeLuc J.. The relationship between neuropsychological measures and the Timed Instrumental Activities of Daily Living task in multiple sclerosis.  Multiple sclerosis (Houndmills, Basingstoke, England). 2007;  13 636-644
    CrossrefPubMedGoogle Scholar
  • 25 Penner IK, Opwis K, Kappos L.. Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis.  J Neurol. 2007;  254 1153-1157
    PubMedGoogle Scholar
  • 26 Piras MR, Magnano I, Canu ED, Paulus KS, Satta WM, Soddu A. et al. . Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological and neurophysiological findings.  J Neurol Neurosurg Psychiatry. 2003;  74 878-885
    CrossrefPubMedGoogle Scholar
  • 27 Benedict RH, Bruce JM, Dwyer MG. et al. . Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.  Arch Neurol. 2006;  63 1301-1306
    CrossrefPubMedGoogle Scholar
  • 28 Charil A, Dagher A, Lerch JP. et al. . Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.  Neuroimage. 2007;  34 509-517
    CrossrefPubMedGoogle Scholar
  • 29 Audoin B, Au MV Duong, Malikova I. et al. . Functional magnetic resonance imaging and cognition at the very early stage of MS.  J Neurol Sci. 2006;  245 87-91
    CrossrefPubMedGoogle Scholar
  • 30 Staffen W, Mair A, Zauner H. et al. . Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task.  Brain. 2002;  125 1275-1282
    CrossrefPubMedGoogle Scholar
  • 31 Penner IK, Rausch M, Kappos L, Opwis K, Radu EW.. Analysis of impairment related functional architecture in MS patients during performance of different attention tasks.  J Neurol. 2003;  250 461-472
    PubMedGoogle Scholar
  • 33 Weinstein A, Schwid SR, Schiffer RB. et al. . Neuropsychologic status in multiple sclerosis after treatment with glatiramer.  Arch Neurol. 1999;  56 319-324
    CrossrefPubMedGoogle Scholar
  • 32 Fischer JS, Priore RL, Jacobs LD. et al. . Neuropsychological effects of interferon beta–1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group.  Ann Neurol. 2000;  48 885-892
    CrossrefPubMedGoogle Scholar
  • 34 Greene YM, Tariot PN, Wishart H. et al. . A 12–week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments.  J Clin Psychopharmacol. 2000;  20 350-356
    CrossrefPubMedGoogle Scholar
  • 35 Krupp LB, Christodoulou C, Melville P. et al. . Donepezil improved memory in multiple sclerosis in a randomized clinical trial.  Neurology. 2004;  63 1579-1585
    CrossrefPubMedGoogle Scholar
  • 36 Lovera J, Bagert B, Smoot K. et al. . Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo–controlled trial.  Multiple sclerosis (Houndmills, Basingstoke, England). 2007;  13 376-385
    PubMedGoogle Scholar
  • 37 Heesen C, Romberg A, Gold S, Schulz KH.. Physical exercise in multiple sclerosis: supportive care or a putative disease–modifying treatment.  Expert Rev Neurother. 2006;  6 347-355
    CrossrefPubMedGoogle Scholar
  • 38 Thomas PW, Thomas S, Hillier C, Galvin K, Baker R.. Psychological interventions for multiple sclerosis. Cochrane database of systematic reviews
    Google Scholar
  • 39 Jonsson A., Korfitzen M. E., Heltberg A., Ravnborg H. M., Byskov–Ottosen E.. Effects of neuropsychological treatment in patients with multiple sclerosis.  Acta Neurol Scand. 1993;  88 394-400
    CrossrefPubMedGoogle Scholar
  • 40 Rodgers D, Khoo K, MacEachen M, Oven M, Beatty WW.. Cognitive therapy for multiple sclerosis: a preliminary study.  Altern Ther Health Med. 1996;  2 70-74
    PubMedGoogle Scholar
  • 41 Plohman AM, Kappos L, Ammann W. et al. . Computer assisted retraining of attentional impairments in patients with multiple sclerosis.  J Neurol Neurosurg Psychiatry. 1998;  64 455-462
    CrossrefPubMedGoogle Scholar
  • 42 Mendozzi L, Pugnetti L.. Computer–assisted memory retraining of patients with multiple sclerosis.  Ital J Neurol Sci. 1998;  19 431-434
    CrossrefPubMedGoogle Scholar
  • 43 Lincoln NB, Dent A, Harding J. et al. . Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis.  J Neurol Neurosurg Psychiatry. 2002;  72 93-98
    CrossrefPubMedGoogle Scholar
  • 44 Lincoln B. N., Dent A., Harding J.. Treatment of cognitive problems for people with multiple sclerosis.  International Journal of Therapy and Rehabilitation. 2003;  10 412-416
    PubMedGoogle Scholar
  • 45 Chiaravalloti ND, Demaree H, Gaudino EA, DeLuca J.. Can the repetition effect maximize learning in multiple sclerosis?.  Clinical rehabilitation. 2003;  17 58-68
    CrossrefPubMedGoogle Scholar
  • 46 Solari A, Motta A, Mendozzi L. et al. . Computer–aided retraining of memory and attention in people with multiple sclerosis: a randomized, double–blind controlled trial.  J Neurol Sci. 2004;  222 99-104
    CrossrefPubMedGoogle Scholar
  • 47 Tesar N, Bandion K, Baumhackl U.. Efficacy of a neuropsychological training programme for patients with multiple sclerosis – a randomised controlled trial.  Wiener klinische Wochenschrift. 2005;  117 747-754
    CrossrefPubMedGoogle Scholar
  • 48 Penner K. I., Kappos L., Rausch M., Opwis K., Radu W. E.. Therapy–induced plasticity of cognitive functions in MS patients: insights from fMRI.  J Physiol. 2006;  99 455-462
    PubMedGoogle Scholar
  • 49 Hildebrandt H, Lanz M, Hahn HK. et al. . Cognitive training in MS: effects and relation to brain atrophy.  Restor Neurol Neurosci. 2007;  25 33-43
    PubMedGoogle Scholar
  • 50 Heesen C, Bohm J, Reich C. et al. .Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Multiple sclerosis (Houndmills, Basingstoke, England) 2008
    Google Scholar

Korrespondenz

PD Dr. med. Christoph Heesen

Institut für Neuroimmunologie und klinische MS–Forschung

Martinstraße 52

20246 Hamburg

Email: heesen@uke.uni-hamburg.de